APA (7th ed.) Citation

Uslu, N., Hancer, V. S., & Kucukkaya, R. D. (2025). The Impact of ASXL1 Gene Mutations on Clinical Course and Prognosis in Myeloproliferative Neoplasms. European Archives of Medical Research, 41(3), 154. https://doi.org/10.14744/eamr.2025.49002

Chicago Style (17th ed.) Citation

Uslu, Neslihan, Veysel Sabri Hancer, and Reyhan Diz Kucukkaya. "The Impact of ASXL1 Gene Mutations on Clinical Course and Prognosis in Myeloproliferative Neoplasms." European Archives of Medical Research 41, no. 3 (2025): 154. https://doi.org/10.14744/eamr.2025.49002.

MLA (9th ed.) Citation

Uslu, Neslihan, et al. "The Impact of ASXL1 Gene Mutations on Clinical Course and Prognosis in Myeloproliferative Neoplasms." European Archives of Medical Research, vol. 41, no. 3, 2025, p. 154, https://doi.org/10.14744/eamr.2025.49002.